Video

'Knowledge is Power' in Genetic Testing for Hereditary Cancer

Having the right understanding and information of a patient’s genetics can not only help treat cancer but also help prevent it.

Patients who are unsure about undergoing genetic testing but may have a genetic predisposition to cancer should consider the positive impact their results may have on their health, whether they have been diagnosed or not, according to Dr. Lauren Carcas.

Carcas, a medical oncologist from the Miami Cancer Institute, recently sat down with CURE® at the 37th Annual Miami Breast Cancer Conference® and CURE® Educated Patient Breast Cancer Summit to talk about the importance of genetic testing, and how it can inform treatment decisions in individuals with cancer.

Transcription:

I always argue that knowing family history is arguably one of the most important things to know about what your risk is for breast cancer. I think that genetic testing is a situation of “knowledge is power”.

If you know your risk, you can potentially take action to reduce that risk, potentially nearly eliminate that risk. But if you already have a diagnosis of breast cancer, it’s really important because that actually might impact your treatment decision.

Really, you have to be your own advocate, and part of advocating for yourself is knowing the total history and knowing the total diagnosis. Knowing that you have a gene mutation that is the underlying cause of your diagnosis is really important.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors and text.
Related Content